HSP60 was also reported to interact with and activate β-catenin [61], and can act as a ligand to Toll like receptor 4 (TLR4) that can activate the NF-κB pathway which is implicated in tumor development through creating a state chronic inflammation that favor tumor growth [62]. Here, NFKB1 is linked to neoplasm.